Windlas Biotech Limited - IPO details

The company was incorporated as 'Windlas Biotech Limited' on February 19, 2001. The Company is one of the leading in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India in terms of revenue. With over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage form and significant experience in providing specialized capabilities, including, high potency, controlled substances and low-solubilify. Windlas Biotech provides a comprehensive range of  CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics.

Market Share:- In 2020 Windlas Biotech Limited's market share was approximately 1.5% in terms of revenue in the domestic formulations CDMO industry.

Sales Process:- The company also sell their own branded products in the trade generics and OTC market as well as export generic products to several countries.  

Current Focus:- Windlas Biotech Limited currently focus on launching new complex generic products in chronic therapeutic category linked in to lifestyle related disorders.

Business Verticals:- The Company has three distinct strategic business verticals.

1. CDMO Service and Products
2. Domestic Trade Generics and over-the-counter Brands
3. Exports

All verticals are supported by a network of R&D laboratories and manufacturing facilities which in turn are supported by various functions, including supply chain, inventory, finance and human resources.

Company Strengths:-

1. Leading CDMO in India with a focus on the chronic therapeutic category.
2. Innovative Portfolio of complex generic products supported by robust R&D Capabilities.
3. Efficient and quality compliant manufacturing facilities with significant entry barriers.
4. Strong and long-term relationships with leading Indian pharmaceutical Companies
5. Consistent track record of financial performance
6. Experienced Professional and Technical Qualified Management Team

Financial Reports:-

Particulars	Years (amt in Millions)
	31-12-2020	31-03-2020	31-03-2019
Total Assets	3158.83	3384.88	2981.80
Total Revenue	3230.94	3313.39	3565.76
Profit After Tax	96.74	162.13	638.22

 

IPO Details:-

IPO Opening Date	4/08/2021
IPO Closing Date	06/08/2021
Face Value	5 Rs. Per Equity Share
IPO Price	Rs. 448 to Rs.460 per Share
Market Lot	30 Shares
Listing At	BSE, NSE
Issue Size	401.54 Cr

IPO Table:-

IPO Open Date	04/08/2021
IPO Close Date	06/08/2021
Allotment Date	11/08/2021
Listing Date	17/08/2021

  

IPO Lot Size:-

minimum 1 lot (30 shares, amt 13800 Rs.) maximum 14 lots (420 Shares, amt 193200Rs.)

Our Suggestion 

Recommended for short term